GLP-1 drugs
Scope
Date
~
-
Asset management
Samsung Asset Management's bond-type ETF assets exceed $7.9 billion
Investment in South Korea is pouring into bond-type exchange-traded funds (ETFs) under the anticipation that interest rate hikes end this year. Such...
Feb 10, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma wins permission from Singapore for Nabota
South Korea's drug development company Daewoong Pharmaceutical said on Thursday that it received on Jan. 20 product approval for its botulinum toxin...
Feb 10, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharmaceutical reports record-high revenue in 2022
South Korea's Hanmi Pharmaceutical Co. last year saw record-high performance thanks to its self-developed drugs, surpassing its previous best year o...
Feb 09, 2023 (Gmt+09:00)
-
Corporate bonds
SK Hynix set for largest-ever corporate bond issue at bargain prices
SK Hynix Inc., the world’s second-largest memory chipmaker, is gearing up for its largest-ever corporate bond issue in South Korea at lower-th...
Feb 08, 2023 (Gmt+09:00)
-
Artificial intelligence
SK Telecom to launch multimodal AI to match ChatGPT
South Korea’s SK Telecom Co. will adopt natural language generation and processing capabilities for its nascent artificial intelligence servic...
Feb 08, 2023 (Gmt+09:00)
-
Electronics
LG makes big B2B push to regain momentum, boost profits: CEO
South Korea’s home appliance giant LG Electronics Inc. is stepping up efforts to enhance its presence in the global business-to-business marke...
Feb 08, 2023 (Gmt+09:00)
-
Bio & Pharma
Korean biopharma, biotech companies scale up as sales balloon
South Korea’s biotech and biopharmaceutical companies are growing big with their sales rising above 1 trillion won ($796 million) last year on...
Feb 07, 2023 (Gmt+09:00)
-
Foreign exchange
S.Korea-Australia renew $8.1 bn currency swap deal for 5 years
The Bank of Korea (BOK) and the Australian Central Bank have agreed to extend the valid date of the current Australian dollar/won currency swap cont...
Feb 07, 2023 (Gmt+09:00)
-
Foreign exchange
Korean won falls on firm US jobs data, new BOJ head report
The South Korean won currency skidded to a four-week low on Monday as stronger-than-expected US employment data renewed expectations that the Federa...
Feb 06, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Boryung receives EU GMP certification
South Korean pharmaceutical company Boryung announced that its production facility for anti-cancer injections in Yesan, South Chungcheong Province, ...
Feb 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Chong Kun Dang, Synaffix ink deal to introduce ADC technology
Chong Kun Dang Pharmaceutical Corp. said on Monday that it has signed a contract with Dutch biotechnology firm Synaffix B.V for the use of antibody-...
Feb 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong receives approval for its GERD drug Fexuclue in Ecuador
Daewoong Pharmaceutical said Friday that it has obtained marketing authorization from Ecuador's National Agency for Health Regulation, Control and S...
Feb 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Prestige Biopharma submits clinical trial plan in Australia
Prestige Biopharma, a Singapore-based biopharmaceutical company with operations in South Korea and the US, has applied to the Australian clini...
Feb 03, 2023 (Gmt+09:00)
-
Earnings
Meritz Securities poised to become Korea’s No. 1 for first time
Meritz Securities Co., once a mid-tier securities firm in South Korea, is expected to command the local market as No. 1 after earning more than 1 tr...
Feb 03, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Cell's AB-101 NK therapy achieves FDA fast-track status
South Korea's bio firm GC Cell announced on Wednesday that its US affiliate Artiva Biotherapeutics has received fast-track designation from the US F...
Feb 02, 2023 (Gmt+09:00)
-
Markets
Kim&Chang sets to enter Indonesia's legal market
Kim & Chang, South Korea's leading law firm, is poised to expand into Indonesia, joining the race among major legal firms seeking a foothold in ...
Feb 02, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi's Rolvedon set to post $10 mn in Q4 net sales in US
South Korean drugmaker Hanmi Pharmaceutical Co.’s neutropenia agent, Rolvedon (eflapegrastim-xnst), is forecast to achieve about $10 million i...
Feb 02, 2023 (Gmt+09:00)
-
Bio & Pharma
Korea's InCerebro to leverage AI to identify drug candidates
South Korean AI-based drug developer InCerebro aims to identify potential drug candidates using molecular modeling technology, according to its CEO ...
Feb 01, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Daewoong Pharmaceutical to export tech to British company
South Korea's Daewoong Pharmaceutical has licensed a new drug candidate for idiopathic pulmonary fibrosis (IPF) to CS Pharmaceuticals (CSP) of the U...
Feb 01, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
Korean Air launches development of Korean regional GPS system
South Korea's national flag carrier Korean Air Lines Co. on Tuesday announced the start of its development of the Korean Positioning System (KPS), a...
Feb 01, 2023 (Gmt+09:00)
-
Airlines
South Korea's Jeju Air to open up Indonesian skies
Jeju Air Co. and Indonesia's largest airline corporation will work together to develop flight routes and discover new tourism business opportunities...
Jan 31, 2023 (Gmt+09:00)
-
Aerospace & Defense
Hanwha kickstarts localization of 1,000-hp gas turbine engine components
A project to lengthen the lifecycle of 1,000-horsepower gas turbine engine core components and materials, which is led by Hanwha Aerospace Co. locat...
Jan 31, 2023 (Gmt+09:00)
-
Pension funds
NPS underperforms global peers by returns for Q1-Q3 2022
South Korea's National Pension Service (NPS), the world's third-largest pension fund, ranked 10th out of the global 42 state-owned investors by rate...
Jan 31, 2023 (Gmt+09:00)
-
Bio & Pharma
JW Pharma to put AI into new drug ingredient development
South Korea's drug developer JW Pharmaceutical is expanding the scope of its artificial intelligence (AI) uses from new drug research to the develop...
Jan 30, 2023 (Gmt+09:00)
-
Korean startups
A-Team Ventures succeeds in attracting $4.1 mn investment from LX
A-Team Ventures, which runs an online manufacturing platform "Capa," said on Friday that it has raised a Series B funding of 5 billion won ($4.1 mil...
Jan 27, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea, Japan compete in gastroesophageal reflux drug market
South Korea is battling Japan again, this time on the global market to treat gastroesophageal reflux disease (GERD). South Korea's pharmaceutical pr...
Jan 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Bridge Biotherapeutics, Pinotbio develop lung cancer treatment
South Korea's biotech companies Bridge Biotherapeutics Inc. and Pinotbio on Thursday said they will jointly develop new antibody-drug conjugates (AD...
Jan 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Inventage Lab launches clinical trials for addiction treatment in Australia
South Korea's Inventage Lab, a developer of a drug delivery system platform, on Wednesday said it received approval from the Human Research Ethics C...
Jan 26, 2023 (Gmt+09:00)
-
AgTech
Korean tractor exports hit record high of $1.3 bn in 2022
Exports of South Korean tractors hit a fresh record high for the second consecutive year in 2022, according to Korea Customs Service on Jan. 24. Kor...
Jan 25, 2023 (Gmt+09:00)
-
Shipping & Shipbuilding
HSD Engine's order volume exceeds $162.1 million in one month
Growth in shipbuilding orders has greatly boosted the sales of manufacturers of related equipment such as ship engines. South Korea's HSD Engine, wh...
Jan 25, 2023 (Gmt+09:00)